Functional role of glycosaminoglycans in decellularized lung extracellular matrix. (15th January 2020)

• Record Type: Journal Article
• Authors: Uhl, Franziska E.; Zhang, Fuming; Pouliot, Robert A.; Uriarte, Juan J.; Rolandsson Enes, Sara; Han, Xiaorui; Ouyang, Yilan; Xia, Ke; Westergren-Thorsson, Gunilla; Malmström, Anders; Hallgren, Oskar; Linhardt, Robert J.; Weiss, Daniel J.
• Is Part Of: Acta biomaterialia. Volume 102(2020)
• Page Start: 231
• Page End: 246
• Publication Date: 2020-01-15
• Subjects: Lung -- Decellularization -- Glycosaminoglycan -- Matrix-associated growth factors -- COPD -- Extracellular matrix gel; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2019.11.029
• Languages: English
• ISSNs: 1742-7061

Abstract

Highlights: Lung decellularization results in differential loss of glycosaminoglycans (GAGs). Specific sulfation patterns of GAGs are differentially depleted. Remaining GAGs are unable to bind key matrix-associated growth factors. Combination of GAGs and matrix-associated growth factors differentially effects growth of three different types of lung cells cultured on or embedded within decellularized human lung gels. Abstract: Despite progress in use of decellularized lung scaffolds in ex vivo lung bioengineering schemes, including use of gels and other materials derived from the scaffolds, the detailed composition and functional role of extracellular matrix (ECM) proteoglycans (PGs) and their glycosaminoglycan (GAG) chains remaining in decellularized lungs, is poorly understood. Using a commonly utilized detergent-based decellularization approach in human autopsy lungs resulted in disproportionate losses of GAGs with depletion of chondroitin sulfate/dermatan sulfate (CS/DS) > heparan sulfate (HS) > hyaluronic acid (HA). Specific changes in disaccharide composition of remaining GAGs were observed with disproportionate loss of NS and NS2S for HS groups and of 4S for CS/DS groups. No significant influence of smoking history, sex, time to autopsy, or age was observed in native vs. decellularized lungs. Notably, surface plasmon resonance demonstrated that GAGs remaining in decellularized lungs were unable to bind key matrix-associated growth factors FGF2, HGF, and TGFβ1. Growth of lung epithelial, pulmonary vascular, and stromal cells cultured on the surface of or embedded within gels derived from decellularized human lungs was differentially and combinatorially enhanced by replenishing specific GAGs and FGF2, HGF, and TGFβ1. In summary, lung decellularization results in loss and/or dysfunction of specific GAGs or side chains significantly affecting matrix-associated growth factor binding and lung cell metabolism. GAG and matrix-associated growth factor replenishment thus needs to be incorporated into schemes for investigations utilizing gels and other materials produced from decellularized human lungs. Statement of significance: Despite progress in use of decellularized lung scaffolds in ex vivo lung bioengineering schemes, including use of gels and other materials derived from the scaffolds, the detailed composition and functional role of extracellular matrix (ECM) proteoglycans (PGs) and their glycosaminoglycan (GAG) chains remaining in decellularized lungs, is poorly understood. In the current studies, we demonstrate that glycosaminoglycans (GAGs) are significantly depleted during decellularization and those that remain are dysfunctional and unable to bind matrix-associated growth factors critical for cell growth and differentiation. Systematically repleting GAGs and matrix-associated growth factors to gels derived from decellularized human lung significantly and differentially affects cell growth. These studies highlight the importance of considering GAGs in decellularized lungs and their derivatives. Graphical abstract: Image, graphical abstract